|
| C14H11ClO |
|
Helicobacter |
Biofilm |
Preclinical (in vivo) |
Di Fermo P, et al. 2020. Antibiotics (Basel) |
|
| 4-[(E)-2-(4-methylphenyl)ethenyl]phenol |
|
Helicobacter |
Biofilm |
Preclinical (in vivo) |
Di Fermo P, et al. 2020. Antibiotics (Basel) |
|
| Resveratrol |
|
Aeromonas
Helicobacter
Staphylococcus |
Biofilm
Biofilm
α-hemolysin |
Preclinical (in vitro)
Preclinical (in vivo)
Preclinical (in vivo) |
Santos CA, et al. 2021. Front Microbiol
Di Fermo P, et al. 2020. Antibiotics (Basel)
Duan J, et al. 2018. Emerg Microbes Infect |
|
| Myricetin |
|
Helicobacter
Listeria
Staphylococcus |
Biofilm
LLO (Listeriolysin O)
Others; Adherence; Biofilm |
Preclinical (in vitro)
Preclinical (in vitro)
Preclinical (in vitro) |
Krzyzek P, et al. 2021. Int J Mol Sci
Wang J, et al. 2015. Sci Rep
Hu P, et al. 2021. Int J Med Microbiol |
|
| Amentoflavone |
|
Helicobacter
Listeria |
Biofilm
LLO (Listeriolysin O) |
Preclinical (in vitro)
Preclinical (in vivo) |
Spiegel M, et al. 2021. Molecules
Tingting W, et al. 2022. Br J Pharmacol |
|
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
